🌍 Last week, FAIRR participated in the World Anti-Microbial Resistance Congress which brought together global stakeholders to discuss strategies and innovations around #AntimicrobialResistance. 💊 During a fireside chat, Emma Berntman, PhD, FAIRR’s Senior Engagement Specialist, and Maria Larsson Ortino, Senior Global ESG Manager at Legal & General Investment Management (LGIM), explored the role investors can play in mitigating the development of #AMR. ✍️ They discussed the value of instigating stewardship dialogues with companies and policymakers, spotlighting concrete examples such as the latest investor statement convened by the Investor Action on Antimicrobial Resistance (IAAMR) initiative and the investor guide on AMR co-authored by FAIRR and MSCI Sustainability Institute. More broadly, participants of the Congress reaffirmed the need for increased funding of new antimicrobials and highlighted the opportunities #ArtificialIntelligence can provide, as well as the continued need for cross-disciplinary collaboration. While it was encouraging to see more discussions on the environmental aspect of antimicrobial contamination of #wastewater than in previous years, agricultural use of antibiotics was not covered as extensively - despite nearly 75% of global antibiotic use occuring in animal agriculture. Learn more about FAIRR’s Antibiotics & Health workstream ➡️ https://lnkd.in/eh7xM8br
Thank you Emma Berntman, PhD, Anna Shattles and FAIRR Initiative for another excellent panel on AMR and how we as investors see AMR as a systemic risk and how we have an important role to play in stemming the rise of AMR.
Chief Executive Officer at Nutrivert
7moMore fine work by Emma Berntman.